Drug Shortage Report for CEFAZOLIN FOR INJECTION, USP

Last updated on 2021-10-15 History
Report ID 145717
Drug Identification Number 02401029
Brand name CEFAZOLIN FOR INJECTION, USP
Common or Proper name Cefazolin for Injection, USP 100 g SmartPak®
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) CEFAZOLIN
Strength(s) 100G
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 100 g
ATC code J01DB
ATC description OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2021-09-24
Actual start date
Estimated end date 2021-10-14
Actual end date 2021-10-14
Shortage status Resolved
Updated date 2021-10-15
Company comments
Health Canada comments
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2021-10-15 English Compare
v11 2021-10-14 French Compare
v10 2021-10-14 English Compare
v9 2021-10-13 French Compare
v8 2021-10-13 English Compare
v7 2021-10-06 French Compare
v6 2021-10-06 English Compare
v5 2021-10-05 French Compare
v4 2021-10-05 English Compare
v3 2021-09-25 English Compare
v2 2021-09-15 French Compare
v1 2021-09-15 English Compare